Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Cardinal to divest drug distribution business in China to Shanghai Pharma By PBR Staff Writer
Cardinal Health, an Ohio-based health care services company has signed a deal to divest its drug distribution business in China to Shanghai Pharmaceuticals (Shanghai Pharma) for $557m.
Production & Manufacturing > Manufacturing > News
Sumitomo to buy 20% stake in Sawai America for $211m By PBR Staff Writer
Sumitomo Corporation of Americas (SCOA) has agreed to acquire 20% interest in Sawai Pharmaceutical’s US subsidiary Sawai America (SAI) for around $211m.
Production & Manufacturing > Manufacturing > News Pfizer to exit from Chinese generic drug JV with Hisun By PBR Staff Writer
Pfizer will exit from Hisun-Pfizer Pharmaceuticals, its Chinese joint venture (JV) for generic drugs, by divesting 49% stake to Sapphire I (HK) Holdings for an undisclosed price.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Valeant to divest Sprout Pharmaceuticals to former owners
By PBR Staff Writer
Valeant Pharmaceuticals International's affiliate has agreed to divest its female libido-pill business Sprout Pharmaceuticals to a buyer associated with the latter’s former shareholders.
Production & Manufacturing > Manufacturing > News
Torrent to acquire Unichem's branded business of India and Nepal
Torrent Pharmaceuticals has entered into a definitive binding agreement with Unichem to acquire its branded business of India and Nepal (India business) for a consideration of Rs3600 crores.
Production & Manufacturing > Manufacturing > News
Celonic acquires Glycotope’s bio-manufacturing plant in Germany
Celonic, a privately owned CDMO based in Basel, Switzerland, has completed the acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany.
Production & Manufacturing > Manufacturing > News
FDA approves new dosing for Xarelto to reduce risk of VTE
Janssen Pharmaceuticals reported that 10mg once-daily dose of Xarelto (rivaroxaban) has been approved by the US Food and Drug Administration (FDA) for reducing the continued risk for recurrent venous thromboembolism (VTE) after at least six months of initial anticoagulation therapy.
Production & Manufacturing > Manufacturing > News
Lannett, Celgene sign settlement and license agreement related to Thalomid
Lannett has entered into a settlement and license agreement with Celgene, which resolves patent infringement litigation in the US related to Celgene's Thalomid.
Production & Manufacturing > Manufacturing > News
Novartis to buy nuclear medicine firm Advanced Accelerator Applications for $3.9bn
By PBR Staff Writer
Novartis has agreed to acquire French radiopharmaceutical company Advanced Accelerator Applications (AAA) for $3.9bn to strengthen its oncology presence.
Production & Manufacturing > Manufacturing > News
Teva loses Copaxone patent dispute case to Mylan in UK
By PBR Staff Writer
The UK High Court of Justice has given a decision in favor of Mylan and Synthon over their dispute concerning the patent of Teva Phamaceutical Industries’ multiple sclerosis (MS) treatment Copaxone which was ruled to be invalid due to obviousness.
Production & Manufacturing > Manufacturing > News
Regeneron Pharmaceuticals to invest $100m in Irish facility
By PBR Staff Writer
US-based Regeneron Pharmaceuticals will invest an additional $100m to expand its bioprocessing campus in Limerick, Ireland, to increase its drug substance production capacity.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests